CWK Short Volume
Cushman & Wakefield plc (CWK) operates in the Real Estate sector, specifically the Real Estate - Services industry, with a market capitalization near $3.06B, listed on NYSE, employing roughly 52,000 people, carrying a beta of 1.50 to the broader market. Cushman & Wakefield plc, together with its subsidiaries, provides commercial real estate services under the Cushman & Wakefield brand in the United States, Australia, the United Kingdom, and internationally. Led by Michelle Marie MacKay, public since 2018-08-02.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-05-15
- Short Volume
- 487.3K
- Total Volume
- 900.6K
- Short %
- 54.11%
- 30-Day Avg Short %
- 54.38%
Showing 30 days of FINRA short volume data for Cushman & Wakefield plc.
Learn how short volume is reported and how to read the data →
Frequently asked CWK short volume questions
- What is the daily CWK short volume?
- As of May 15, 2026, Cushman & Wakefield plc (CWK) short volume is 487.3K shares against 900.6K total reported volume, or 54.11% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is CWK short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does CWK short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.